Fresenius SE KGaA (XTER:FRE) Net Interest Margin (Bank Only) %


XTER:FRE Fresenius SE & Co KGaA XTER:FRE
67 GF Score
Price €40.07
GF Value €36.55
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Fresenius SE KGaA Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

XTER:FRE
67GF Score
Fresenius SE & Co KGaA XTER:FRE
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Fresenius SE KGaA (XTER:FRE) Overvalued in 2026?

Based on GuruFocus' analysis, Fresenius SE KGaA stock appears to be overvalued. The current stock price of €40.07 is trading 9.6% above its estimated GF Value™ of €36.55. GuruFocus considers Fresenius SE KGaA to be Fairly Valued.

Key valuation signals for XTER:FRE:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €36.55 vs. price of €40.07 (9.6% above fair value)
  • GF Score™: 67/100 with 5 warning signs

No single metric tells the full story. See the XTER:FRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fresenius SE KGaA Business Description

Address Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.
67GF Score

Get the complete analysis for XTER:FRE

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€40.07
Price
€36.55
GF Value